Early-life toxic insults and onset of sporadic neurodegenerative diseases—An overview of experimental studies

Current Topics in Behavioral Neurosciences

Volumn 29, Issue , 2016, Pages 231-264

  Tartaglione, Anna Maria ^a,b   Venerosi, Aldina ^a   Calamandrei, Gemma ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Alzheimer s disease; Exposome; Heavy metals; Maternal immune activation; Neurodevelopment; Parkinson s disease; Pesticides

Indexed keywords

ATRAZINE; IRON; LEAD; MANGANESE; MATERNAL ANTIBODY; PESTICIDE; TYROSINE 3 MONOOXYGENASE; POLLUTANT;

ALZHEIMER DISEASE; COGNITION; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DNA DAMAGE; DNA METHYLATION; ENVIRONMENTAL EXPOSURE; GENE MUTATION; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; MEMORY; NERVE CELL PLASTICITY; NEUROFIBRILLARY TANGLE; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PHOSPHORYLATION; PRIORITY JOURNAL; ADVERSE EFFECTS; ANIMAL; DISEASE MODEL; FEMALE; NEURODEGENERATIVE DISEASES; POLLUTANT; PREGNANCY; PRENATAL EXPOSURE; TOXICITY;

ANIMALS; DISEASE MODELS, ANIMAL; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; NEURODEGENERATIVE DISEASES; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 84978828128     PISSN: 18663370     EISSN: 18663389     Source Type: Book Series    
DOI: 10.1007/7854_2015_416     Document Type: Chapter

References (146)

1. Allen JL, Liu X, Weston D et al (2014) Consequences of developmental exposure to concentrated ambient ultrafine particle air pollution combined with the adult paraquat and maneb model of the Parkinson’s disease phenotype in male mice. Neurotoxicology 41:80-88
2. Androutsopoulos VP, Hernandez AF, Liesivuori J et al (2013) A mechanistic overview of health associated effects of low levels of organochlorine and organophosphorous pesticides. Toxicology 307:89-94
3. Ashok A, Rai NK, Tripathi S et al (2015) Exposure to As-, Cd-, and Pb-mixture induces Aβ, amyloidogenic APP processing and cognitive impairments via oxidative stress-dependent neuroinflammation in young rats. Toxicol Sci 143(1):64-80
4. Bakulski KM, Rozek LS, Dolinoy DC et al (2012) Alzheimer’s disease and environmental exposure to lead: the epidemiologic evidence and potential role of epigenetics. Curr Alzheimer Res 9(5):563-573
5. Baldi I, Gruber A, Rondeau V et al (2011) Neurobehavioral effects of long-term exposure to pesticides: results from the 4-year follow-up of the PHYTONER study. Occup Environ Med 68 (2):108-115
6. Ballard C, Gauthier S, Corbett A et al (2011) Alzheimer’s disease. Lancet 377(9770):1019-1031
7. Banks EC, Ferretti LE, Shucard DW (1997) Effects of low level lead exposure on cognitive function in children: a review of behavioral, neuropsychological and biological evidence. Neurotoxicology 18(1):237-281
8. Barker DJ, Gluckman PD, Godfrey KM et al (1993) Fetal nutrition and cardiovascular disease in adult life. Lancet 341(8850):938-941
9. Barlow BK, Richfield EK, Cory-Slechta DA et al (2004) A fetal risk factor for Parkinson’s disease. Dev Neurosci 26(1):11-23
10. Barlow BK, Cory-Slechta DA, Richfield EK et al (2007) The gestational environment and Parkinson’s disease: evidence for neurodevelopmental origins of a neurodegenerative disorder. Reprod Toxicol 23(3):457-470
11. Basha MR, Wei W, Bakheet SA et al (2005) The fetal basis of amyloidogenesis: exposure to lead and latent overexpression of amyloid precursor protein and beta-amyloid in the aging brain. J Neurosci 25(4):823-829
12. Bellinger DC (2009) Interpreting epidemiologic studies of developmental neurotoxicity: conceptual and analytic issues. Neurotoxicol Teratol 31:267-274
13. Bellinger DC (2014) Mercury and pregnancy. Birth Defects Res A Clin Mol Teratol 100:1-3
14. Bihaqi SW, Zawia NH (2013) Enhanced taupathy and AD-like pathology in aged primate brains decades after infantile exposure to lead (Pb). Neurotoxicology 39:95-101
15. Bihaqi SW, Bahmani A, Subaiea GM et al (2014) Infantile exposure to lead and late-age cognitive decline: relevance to AD. Alzheimers Dement 10(2):187-195
16. Billnitzer AJ, Barskaya I, Yin C et al (2013) APP independent and dependent effects on neurite outgrowth are modulated by the receptor associated protein (RAP). J Neurochem 124(1):123-132
17. Blennow K, de Leon MJ, Zetterberg H (2006) Alzheimer’s disease. Lancet 368(9533):387-403
18. Bolin CM, Basha R, Cox D et al (2006) Exposure to lead and the developmental origin of oxidative DNA damage in the aging brain. FASEB J 20(6):788-790
19. Bugiani O (2011) Alzheimer’s disease: ageing-related or age-related? New hypotheses from an old debate. Neurol Sci 32:1241-1247
20. Cai Z, Fan LW, Kaizaki A et al (2013) Neonatal systemic exposure to lipopolysaccharide enhances susceptibility of nigrostriatal dopaminergic neurons to rotenone neurotoxicity in later life. Dev Neurosci 35(2-3):155-171
21. Caito SW, Aschner M (2015) Mitochondrial redox dysfunction and environmental exposures. Antioxid Redox Signal 23(6):578-595
22. Calne DB, Langston JW (1983) Aetiology of Parkinson’s disease. Lancet 2(8365-8366):1457-1459
23. Campbell A, Oldham M, Becaria A et al (2005) Particulate matter in polluted air may increase biomarkers of inflammation in mouse brain. Neurotoxicology 26:133-140
24. Casado A, Encarnación López-Fernández M, Concepción Casado M et al (2008) Lipid peroxidation and antioxidant enzyme activities in vascular and Alzheimer dementias. Neurochem Res 33(3):450-458
25. Chen GH, Wang H, Yang QG et al (2011) Acceleration of age-related learning and memory decline in middle-aged CD-1 mice due to maternal exposure to lipopolysaccharide during late pregnancy. Behav Brain Res 218(2):267-279
26. Chen L, Yoo SE, Na R et al (2012) Cognitive impairment and increased Aβ levels induced by paraquat exposure are attenuated by enhanced removal of mitochondrial H(2)O(2). Neurobiol Aging 33(2):432.e15-26
27. Chin-Chan M, Navarro-Yepes J, Quintanilla-Vega B (2015) Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases. Front Cell Neurosci 9:124
28. Colborn T (2006) A case for revisiting the safety of pesticides: a closer look at neurodevelopment. Environ Health Perspect 114(1):10-17
29. Cole TB, Beyer RP, Bammler TK et al (2011) Repeated developmental exposure of mice to chlorpyrifos oxon is associated with paraoxonase 1 (PON1)-modulated effects on cerebellar gene expression. Toxicol Sci 123(1):155-169
30. Cordova FM, Aguiar AS Jr, Peres TV et al (2012) In vivo manganese exposure modulates Erk, Akt and Darpp-32 in the striatum of developing rats, and impairs their motor function. PLoS ONE 7(3):e33057
31. Cordova FM, Aguiar AS Jr, Peres TV et al (2013) Manganese-exposed developing rats display motor deficits and striatal oxidative stress that are reversed by Trolox. Arch Toxicol 87 (7):1231-1244
32. Cory-Slechta DA, Thiruchelvam M, Barlow BK et al (2005) Developmental pesticide models of the Parkinson disease phenotype. Environ Health Perspect 113(9):1263-1270
33. Costa LG, Aschner M, Vitalone A et al (2004) Developmental neuropathology of environmental agents. Annu Rev Pharmacol Toxicol 44:87-110
34. Couper J (1837) On the effects of black oxide of manganese when inhaled into the lungs. Br Ann Med Pharm Vital Stat Gen Sci 1:41-42
35. Crawley JN (2012) Translational animal models of autism and neurodevelopmental disorders. Dialogues Clin Neurosci 14:293-305
36. Dal-Pizzol F, Klamt F, Frota ML Jr et al (2001) Neonatal iron exposure induces oxidative stress in adult Wistar rat. Brain Res Dev Brain Res 130(1):109-114
37. Dauer W, Przedborski S (2003) Parkinson’s disease: mechanisms and models. Neuron 39 (6):889-909
38. De Felice A, Ricceri L, Venerosi A, Chiarotti F, Calamandrei G (2015) Multifactorial origin of neurodevelopmental disorders: approaches to understanding complex etiologies. Toxics 3 (1):89-129
39. Di Monte DA (2003) The environment and Parkinson’s disease: is the nigrostriatal system preferentially targeted by neurotoxins. 2(9):531-538
40. Dias V, Junn E, Mouradian MM (2013) The role of oxidative stress in Parkinson’s disease. J Parkinsons Dis 3(4):461-491
41. Dosunmu R, Alashwal H, Zawia NH (2012) Genome-wide expression and methylation profiling in the aged rodent brain due to early-life Pb exposure and its relevance to aging. Mech Ageing Dev 133(6):435-443
42. Eaton DL, Daroff RB, Autrup H et al (2008) Review of the toxicology of chlorpyrifos with an emphasis on human exposure and neurodevelopment. Crit Rev Toxicol 38(Suppl 2):1-125
43. Eskenazi B, Marks AR, Bradman A et al (2007) Organophosphate pesticide exposure and neurodevelopment in young Mexican-American children. Environ Health Perspect 115:792-798
44. Fan LW, Tien LT, Lin RC et al (2011a) Neonatal exposure to lipopolysaccharide enhances vulnerability of nigrostriatal dopaminergic neurons to rotenone neurotoxicity in later life. Neurobiol Dis 44(3):304-316
45. Fan LW, Tien LT, Zheng B et al (2011b) Dopaminergic neuronal injury in the adult rat brain following neonatal exposure to lipopolysaccharide and the silent neurotoxicity. Brain Behav Immun 25(2):286-297
46. Firestone JA, Lundin JI, Powers KM et al (2010) Occupational factors and risk of Parkinson’s disease: a population-based case-control study. Am J Ind Med 53(3):217-223
47. Fredriksson A, Schröder N, Eriksson P et al (1999) Neonatal iron exposure induces neurobehavioural dysfunctions in adult mice. Toxicol Appl Pharmacol 159(1):25-30
48. Fredriksson A, Schröder N, Eriksson P et al (2000) Maze learning and motor activity deficits in adult mice induced by iron exposure during a critical postnatal period. Brain Res Dev Brain Res 119(1):65-74
49. Garner CC, Zhai RG, Gundelfinger ED et al (2002) Molecular mechanisms of CNS synaptogenesis. Trends Neurosci 25(5):243-251
50. Giacobini E, Mori F, Lai CC (1996) The effect of cholinesterase inhibitors on the secretion of APPS from rat brain cortex. Ann N Y Acad Sci 777:393-398
51. Gilbert SG, Grant-Webster KS (1995) Neurobehavioral effects of developmental methylmercury exposure. Environ Health Perspect 103(Suppl 6):135-142
52. Gillman MW (2005) Developmental origins of health and disease. N Engl J Med 353(17):1848-1850
53. Giorgi O, De Montis G, Porceddu ML et al (1987) Developmental and age-related changes in D1-dopamine receptors and dopamine content in the rat striatum. Brain Res 432(2):283-290
54. Goedert M, Jakes R, Crowther RA et al (1993) The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development. Proc Natl Acad Sci USA 90(11):5066-5070
55. JPND Action Group (2013) Report of the JPND action group. www.jpnd.eu
56. Gupta RK, Hasan KM, Trivedi R et al (2005) Diffusion tensor imaging of the developing human cerebrum. J Neurosci Res 81:172-178
57. Hanson MA (2013) Developmental origins of obesity and non-communicable disease. Endocrinol Nutr 60(Suppl 1):10-11
58. Hayden KM, Norton MC, Darcey D et al (2010) Occupational exposure to pesticides increases the risk of incident AD: the cache county study. Neurology 74(19):1524-1530
59. Heindel JJ, Balbus J, Birnbaum L et al (2015) developmental origins of health and disease: integrating environmental influences. Endocrinology 156(10):3416-3421
60. Heneka MT, Carson MJ, El Khoury J et al (2015) Neuroinflammation in Alzheimer’s disease. Lancet Neurol 14(4):388-405
61. Heppner FL, Ransohoff RM, Becher B (2015) Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci 16(6):358-372
62. Herbstman JB, Sjodin A, Kurzon M et al (2010) Prenatal exposure to PBDEs and neurodevelopment. Environ Health Perspect 118:712-719
63. Hertzman C, Wiens M, Bowering D et al (1990) Parkinson’s disease: a case-control study of occupational and environmental risk factors. Am J Ind Med 17(3):349-355
64. Howe K, Clark MD, Torroja CF et al (2013) The zebrafish reference genome sequence and its relationship to the human genome. Nature 496(7446):498-503
65. Jankovic J (2005) Searching for a relationship between manganese and welding and Parkinson’s disease. Neurology 64(12):2021-2028
66. Jenner P (2003) Oxidative stress in Parkinson’s disease. Ann Neurol 53(Suppl 3):S26-S36
67. Kaur D, Peng J, Chinta SJ et al (2007) Increased murine neonatal iron intake results in Parkinson-like neurodegeneration with age. Neurobiol Aging 28(6):907-913
68. Kim JT, Son MH, Lee DH et al (2015) Partitioning behavior of heavy metals and persistent organic pollutants among feto-maternal bloods and tissues. Environ Sci Technol 49(12):7411-7422
69. Knuesel I, Chicha L, Britschgi M et al (2014) Maternal immune activation and abnormal brain development across CNS disorders. Nat Rev Neurol 10(11):643-660
70. Kovacs GG, Adle-Biassette H, Milenkovic I et al (2014) Linking pathways in the developing and aging brain with neurodegeneration. Neuroscience 269:152-172
71. Krstic D, Madhusudan A, Doehner J et al (2012) Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice. J Neuroinflammation 9:151
72. Kumar A, Leinisch F, Kadiiska MB et al (2015) Formation and implications of alpha-synuclein radical in Maneb-and Paraquat-induced models of Parkinson’s disease. Mol Neurobiol (Epub ahead of print)
73. Lahiri DK, Maloney B, Basha MR et al (2007) How and when environmental agents and dietary factors affect the course of Alzheimer’s disease: the “LEARn” model (latent early-life associated regulation) may explain the triggering of AD. Curr Alzheimer Res 4(2):219-228
74. Lahiri DK, Maloney B, Zawia NH (2009) The LEARn model: an epigenetic explanation for idiopathic neurobiological diseases. Mol Psychiatry 14(11):992-1003
75. Lai BC, Marion SA, Teschke K et al (2002) Occupational and environmental risk factors for Parkinson’s disease. Parkinsonism Relat Disord 8(5):297-309
76. Langston J, Ballard P, Tetrud J et al (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219:979-980
77. Langston JW, Forno LS, Tetrud J et al (1999) Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Ann Neurol 46(4):598-605
78. Lanphear BP, Hornung R, Khoury J et al (2005) Low level environmental lead exposure and children’s intellectual function: an international pooled analysis. Environ Health Perspect 113:894-899
79. Lee J, Freeman JL (2014) Zebrafish as a model for investigating developmental lead (Pb) neurotoxicity as a risk factor in adult neurodegenerative disease: a mini-review. Neurotoxicology 43:57-64
80. Lees AJ, Hardy J, Revesz T (2009) Parkinson’s disease. Lancet 373:2055-2066
81. Li N, Yu ZL, Wang L et al (2010) Increased tau phosphorylation and betaamyloid in the hippocampus of mouse pups by early life lead exposure. Acta Biologica Hungarica 61(2): 123-134
82. Li Y, Sun Y, Yang J et al (2014) Age-dependent dopaminergic dysfunction following fetal exposure to atrazine in SD rats. Environ Toxicol Pharmacol 37(3):1275-1282
83. Ling ZD, Chang Q, Lipton JW et al (2004a) Combined toxicity of prenatal bacterial endotoxin exposure and postnatal 6-hydroxydopamine in the adult rat midbrain. Neuroscience 124 (3):619-628
84. Ling Z, Chang QA, Tong CW et al (2004b) Rotenone potentiates dopamine neuron loss in animals exposed to lipopolysaccharide prenatally. Exp Neurol 190(2):373-383
85. Liou HH, Tsai MC, Chen CJ et al (1997) Environmental risk factors and Parkinson’s disease: a case-control study in Taiwan. Neurology 48(6):1583-1588
86. Logroscino G (2005) The role of early life environmental risk factors in Parkinson disease: what is the evidence? Environ Health Perspect 113(9):1234-1238
87. Mazumdar M, Xia W, Hofmann O et al (2012) Prenatal lead levels, plasma amyloid beta levels, and gene expression in young adulthood. Environ Health Perspect 120:702-707
88. McCormack AL, Thiruchelvam M, Manning-Bog AB et al (2002) Environmental risk factors and Parkinson’s disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiol Dis 10(2):119-127
89. McFarlane AC, Searle AK, Van Hooff M et al (2013) Prospective associations between childhood low-level lead exposure and adult mental health problems: the Port Pirie cohort study. Neurotoxicology 39:11-17
90. McGeer PL, Yasojima K, McGeer EG (2001) Inflammation in Parkinson’s disease. Adv Neurol 86:83-89
91. Meyer U (2014) Prenatal poly(i:C) exposure and other developmental immune activation models in rodent systems. Biol Psychiatry 75(4):307-315
92. Milatovic D, Zaja-Milatovic S, Gupta RC et al (2009) Oxidative damage and neurodegeneration in manganese-induced neurotoxicity. Toxicol Appl Pharmacol 240(2):219-225
93. Miller MW (1986) Effects of alcohol on the generation and migration of cerebral cortical neurons. Science 233:1308-1311
94. Moreira EG, Yu X, Robinson JF et al (2010) Toxicogenomic profiling in maternal and fetal rodent brains following gestational exposure to chlorpyrifos. Toxicol Appl Pharmacol 245(3):310-325
95. Morley R (2006) Fetal origins of adult disease. Semin Fetal Neonatal Med 11(2):73-78
96. Neal AP, Guilarte TR (2010) Molecular neurobiology of lead (Pb(2+)): effects on synaptic function. Mol Neurobiol 42(3):151-160
97. Neal AP, Worley PF, Guilarte TR (2011) Lead exposure during synaptogenesis alters NMDA receptor targeting via NMDA receptor inhibition. Neurotoxicology 32:281-289
98. Nordberg M, Winblad B, Fratiglioni L et al (2000) Lead concentrations in elderly urban people related to blood pressure and mental performance: results from a population-based study. Am J Ind Med 38(3):290-294
99. Nunomura A, Perry G, Aliev G et al (2001) Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60(8):759-767
100. Olden K, Isaac L, Roberts L (2011) Neighborhood-specific epigenome analysis: the pathway forward to understanding gene-environment interactions. N C Med J 72(2):125-127
101. Parrón T, Requena M, Hernández AF et al (2011) Association between environmental exposure to pesticides and neurodegenerative diseases. Toxicol Appl Pharmacol 256(3):379-385
102. Perera FP, Li Z, Whyatt R et al (2009) Prenatal airborne polycyclic aromatic hydrocarbon exposure and child IQ at age 5 years. Pediatrics 124:e195-e202
103. Peris-Sampedro F, Salazar JG, Cabré M et al (2014) Impaired retention in AβPP Swedish mice six months after oral exposure to chlorpyrifos. Food Chem Toxicol 72:289-294
104. Reitz C, Brayne C, Mayeux R (2011) Epidemiology of Alzheimer disease. Nat Rev Neurol 7 (3):137-152
105. Reuhl KR (1991) Delayed expression of neurotoxicity: the problem of silent damage. Neurotoxicology 12(3):341-346
106. Richardson JR, Caudle WM, Wang M et al (2006) Developmental exposure to the pesticide dieldrin alters the dopamine system and increases neurotoxicity in an animal model of Parkinson’s disease. FASEB J 20(10):1695-1697
107. Richardson JR, German D, Levey A (2014) Alzheimer disease risk factors. JAMA Neurol 71 (8):1051
108. Rosas LG, Eskenazi B (2008) Pesticides and child neurodevelopment. Curr Opin Pediatr 20 (2):191-197
109. Rose S, Melnyk S, Pavliv O et al (2012) Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain Transl. Psychiatry 2(7):e134
110. Rossignol DA, Genuis SJ, Frye RE (2014) Environmental toxicants and autism spectrum disorders: a systematic review. Trans Psychiatry 4:e360
111. Roy TS, Seidler FJ, Slotkin TA (2004) Morphologic effects of subtoxic neonatal chlorpyrifos exposure in developing rat brain: regionally selective alterations in neurons and glia. Brain Res Dev Brain Res 148:197-206
112. Salazar JG, Ribes D, Cabré M et al (2011) Amyloid β peptide levels increase in brain of AβPP Swedish mice after exposure to chlorpyrifos. Curr Alzheimer Res 8(7):732-740
113. Sale A, Berardi N, Maffei L (2014) Environment and brain plasticity: towards an endogenous pharmacotherapy. Physiol Rev 94(1):189-234
114. Sandy MS, Armstrong M, Tanner CM et al (1996) CYP2D6 allelic frequencies in young-onset Parkinson’s disease. Neurology 47(1):225-230
115. Santibáñez M, Bolumar F, García AM (2007) Occupational risk factors in Alzheimer’s disease: a review assessing the quality of published epidemiological studies. Occup Environ Med 64 (11):723-732
116. Selkoe DJ, Schenk D (2003) Alzheimer’s disease: molecular understanding predicts amyloid-based therapeutics. Annu Rev Pharmacol Toxicol 43:545-584
117. Sheinerman KS, Umansky SR (2013) Circulating cell-free microRNA as biomarkers for screening, diagnosis and monitoring of neurodegenerative diseases and other neurologic pathologies. Front Cell Neurosci 7:150
118. Shonkoff JP (2000) From neurons to neighborhoods: the science of early childhood development. National Academy Press, Washington
119. Sian-Hülsmann J, Mandel S, Youdim MB et al (2011) The relevance of iron in the pathogenesis of Parkinson’s disease. J Neurochem 118(6):939-957
120. Slotkin TA, Seidler FJ (2009) Oxidative and excitatory mechanisms of developmental neurotoxicity: transcriptional profiles for chlorpyrifos, diazinon, dieldrin, and divalent nickel in PC12 cells. Environ Health Perspect 117:587-596
121. Stangle DE, Strawderman MS, Smith D et al (2004) Reductions in blood lead overestimate reductions in brain lead following repeated succimer regimens in a rodent model of childhood lead exposure. Environ Health Perspect 112:302-308
122. Sun Y, Li YS, Yang JW et al (2014) Exposure to atrazine during gestation and lactation periods: toxicity effects on dopaminergic neurons in offspring by downregulation of Nurr1 and VMAT2. Int J Mol Sci 15(2):2811-2825
123. Tanner CM, Goldman SM, Ross GW et al (2014) The disease intersection of susceptibility and exposure: chemical exposures and neurodegenerative disease risk. Alzheimers Dement 10(3 Suppl):S213-S225
124. Tarantal AF, Berglund L (2014) Obesity and lifespan health-importance of the fetal environment. Nutrients 6(4):1725-1736
125. Tau GZ, Peterson BS (2010) Normal development of brain circuits. Neuropsychopharmacology 35 (1):147-168
126. Thiruchelvam M, Brockel BJ, Richfield EK et al (2000) Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson’s disease? Brain Res 873(2):225-234
127. Thiruchelvam M, Richfield EK, Goodman BM et al (2002) Developmental exposure to the pesticides paraquat and maneb and the Parkinson’s disease phenotype. Neurotoxicology 23(4-5):621-633
128. Thiruchelvam M, McCormack A, Richfield EK et al (2003) Age-related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson’s disease phenotype. Eur J Neurosci 18(3):589-600
129. Tien LT, Cai Z, Rhodes PG et al (2011) Neonatal exposure to lipopolysaccharide enhances methamphetamine-induced reinstated behavioral sensitization in adult rats. Behav Brain Res 224(1):166-173
130. Tien LT, Kaizaki A, Pang Y et al (2013) Neonatal exposure to lipopolysaccharide enhances accumulation of α-synuclein aggregation and dopamine transporter protein expression in the substantia nigra in responses to rotenone challenge in later life. Toxicology 308:96-103
131. Toscano CD, Guilarte TR (2005) Lead neurotoxicity: from exposure to molecular effects. Brain Res Brain Res Rev 49(3):529-554
132. Van Maele-Fabry G, Hoet P, Vilain F et al (2012) Occupational exposure to pesticides and Parkinson’s disease: a systematic review and meta-analysis of cohort studies. Environ Int 1 (46):30-43
133. Venerosi A, Ricceri L, Tait S et al (2012) Sex dimorphic behaviors as markers of neuroendocrine disruption by environmental chemicals: the case of chlorpyrifos. Neurotoxicology 33(6):1420-1426
134. Voorn P, Kalsbeek A, Jorritsma-Byham B et al (1988) The pre-and postnatal development of the dopaminergic cell groups in the ventral mesencephalon and the dopaminergic innervation of the striatum of the rat. Neuroscience 25(3):857-887
135. Vorhees RA (1986) Handbook of behavioral teratology. Plenum Press, New York
136. Wang S, Yan JY, Lo YK et al (2009) Dopaminergic and serotoninergic deficiencies in young adult rats prenatally exposed to the bacterial lipopolysaccharide. Brain Res 1265:196-204
137. Wani WY, Sunkaria A, Sharma DR et al (2014) Caspase inhibition augments Dichlorvos-induced dopaminergic neuronal cell death by increasing ROS production and PARP1 activation. Neuroscience 258:1-15
138. Weisskopf MG, Wright RO, Schwartz J et al (2004) Cumulative lead exposure and prospective change in cognition among elderly men: the VA normative aging study. Am J Epidemiol 160 (12):1184-1193
139. Westerlund M, Hoffer B, Olson L (2010) Parkinson’s disease: exit toxins, enter genetics. Prog Neurobiol 90:146-156
140. Whyatt RM, Liu X, Rauh VA et al (2012) Maternal prenatal urinary phthalate metabolite concentrations and child mental, psychomotor, and behavioral development at 3 years of age. Environ Health Perspect 120:290-295
141. Wild CP (2012) The exposome: from concept to utility. Int J Epidemiol 41:24-32
142. Wilson WW, Shapiro LP, Bradner JM et al (2014) Developmental exposure to the organochlorine insecticide endosulfan damages the nigrostriatal dopamine system in male offspring. Neurotoxicology 44:279-287
143. Winneke G (2011) Developmental aspects of environmental neurotoxicology: Lessons from lead and polychlorinated biphenyls. J Neurol Sci 308:9-15
144. Wright RO, Tsaih SW, Schwartz J et al (2003) Lead exposure biomarkers and mini-mental status exam scores in older men. Epidemiology 14(6):713-718
145. Wu J, Basha MR, Brock B et al (2008) Alzheimer’s disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD. J Neurosci 28(1):3-9
146. Zhu Y, Carvey PM, Ling Z (2007) Altered glutathione homeostasis in animals prenatally exposed to lipopolysaccharide. Neurochem Int 50(4):671-680